Skip to content
Application 019821
- Type
- NDA
- Sponsor
- STIEFEL LABS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SORIATANE | ACITRETIN | CAPSULE;ORAL | 10MG | Yes | No |
| 002 | SORIATANE | ACITRETIN | CAPSULE;ORAL | 25MG | Yes | Yes |
| 003 | SORIATANE | ACITRETIN | CAPSULE;ORAL | 17.5MG | Yes | No |
| 004 | SORIATANE | ACITRETIN | CAPSULE;ORAL | 22.5MG | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0145-0090 | SORIATANE | acitretin | Stiefel Laboratories Inc | NDA | Current |
| 0145-0090 | SORIATANE | acitretin | Stiefel Laboratories Inc | NDA | Current |
| 0145-0090 | SORIATANE | acitretin | Stiefel Laboratories Inc | NDA | Current |
| 0145-0090 | SORIATANE | acitretin | Stiefel Laboratories Inc | NDA | Current |
| 0145-0090 | SORIATANE | acitretin | Stiefel Laboratories Inc | NDA | Current |
| 0145-0091 | SORIATANE | acitretin | Stiefel Laboratories Inc | NDA | Current |
| 0145-0091 | SORIATANE | acitretin | Stiefel Laboratories Inc | NDA | Current |
| 0145-0091 | SORIATANE | acitretin | Stiefel Laboratories Inc | NDA | Current |
| 0145-0091 | SORIATANE | acitretin | Stiefel Laboratories Inc | NDA | Current |
| 0145-0091 | SORIATANE | acitretin | Stiefel Laboratories Inc | NDA | Current |
| 66993-894 | ACITRETIN | acitretin | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-894 | ACITRETIN | acitretin | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-894 | ACITRETIN | acitretin | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-896 | ACITRETIN | acitretin | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-896 | ACITRETIN | acitretin | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-896 | ACITRETIN | acitretin | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |